Diagnostic Molecular Pathology is organized by Mayo Clinic Laboratories and will be held from Apr 15 - 16, 2019 at Hilton Minneapolis, Minneapolis, Minnesota, United States of America. This CME Conference has been approved for a maximum of 12.5 AMA PRA Category 1 Credits™.
Intended Audience :
This program is designed for practicing surgical and molecular pathologists and other medical laboratory scientists or physicians interested in enhancing their delivery of care.
Diagnostic molecular pathology is currently regarded as a fundamental element of surgical pathology. Excellent oncologic care requires that practicing surgical pathologists understand molecular testing platforms, results, and clinical significance. This comprehensive, case-based conference will prepare attendees for both common and uncommon clinical scenarios where molecular testing should be applied, with a focus on cost- and time-effective methodology.
Conference Objectives :
Upon completion of the conference, participants should be able to:
•Identify clinical scenarios where molecular testing is appropriate and inappropriate.
•Discuss the fundamental features of molecular testing platforms.
•Interpret molecular test results.
•Explain the clinical significance of molecular test results.
|Contact No. :||800-533-1710
|Registration Type||End Date||Price|
|PHYSICIANS/SCIENTISTS Registration Fee||22 Mar,2019||USD 700.00|
|RESIDENTS/FELLOWS/ALLIED HEALTH Registration Fee||22 Mar,2019||USD 650.00|